Amy P Abernethy

Publication Activity (10 Years)

Years Active: 2016-2019
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Randomized Controlled Trial

Epidermal Growth Factor Receptor

Top Venues

JMIR human factors

This page only lists publications with an associated author ORCID identifier.

Publications

Sean Khozin, Rebecca A Miksad, Johan Adami, Mariel Boyd, Nicholas R Brown, Anala Gossai, Irene Kaganman, Deborah Kuk, Jillian M Rockland, Richard Pazdur, Aracelis Z Torres, Jizu Zhi, Amy P Abernethy
Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer. Cancer 125 (22) (2019)
Sean Khozin, Kenneth R Carson, Jizu Zhi, Melisa Tucker, Shannon E Lee, David E Light, Melissa D Curtis, Marta Bralic, Irene Kaganman, Anala Gossai, Philip Hofmeister, Aracelis Z Torres, Rebecca A Miksad, Gideon Michael Blumenthal, Richard Pazdur, Amy P Abernethy
Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval. The oncologist 24 (5) (2018)
Tamara J Somers, Sarah A Kelleher, Caroline S Dorfman, Rebecca A Shelby, Hannah M Fisher, Krista Rowe Nichols, Keith M Sullivan, Nelson J Chao, Gregory P Samsa, Amy P Abernethy, Francis J Keefe
An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial. JMIR mHealth and uHealth 6 (3) (2018)
Sean Khozin, Amy P Abernethy, Nathan C Nussbaum, Jizu Zhi, Melissa D Curtis, Melisa Tucker, Shannon E Lee, David E Light, Anala Gossai, Rachael A Sorg, Aracelis Z Torres, Payal Patel, Gideon Michael Blumenthal, Richard Pazdur
Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval. The oncologist 23 (3) (2018)
Martin W Schoen, Ethan M Basch, Lori L Hudson, Arlene E Chung, Tito R Mendoza, Sandra A Mitchell, Diane St Germain, Paul Baumgartner, Laura Sit, Lauren J Rogak, Marwan Shouery, Eve R Shalley, Bryce B Reeve, Maria R Fawzy, Nrupen A Bhavsar, Charles S Cleeland, Deborah Schrag, Amylou C Dueck, Amy P Abernethy
Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR human factors 5 (3) (2018)
Melissa D Curtis, Sandra D Griffith, Melisa Tucker, Michael D Taylor, William B Capra, Gillis Carrigan, Ben Holzman, Aracelis Z Torres, Paul You, Brandon Arnieri, Amy P Abernethy
Development and Validation of a High-Quality Composite Real-World Mortality Endpoint. Health services research 53 (6) (2018)
Gareth J Watts, Katherine Clark, Meera Agar, Patricia M Davidson, Christine McDonald, Lawrence T Lam, Dimitar Sajkov, Nicola McCaffrey, Matthew Doogue, Amy P Abernethy, David C Currow, null null
Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness. BMJ open 6 (11) (2016)